Quiet Harbor 52 / Information services

Services

Guides, comparisons, and research summaries for people following ibogaine research in Texas—organized to make the distinction between research activity, policy change, and routine treatment access easier to see.

Independent context only. This resource does not provide medical care, legal advice, or treatment referrals.
Close-up visual detail accompanying the Texas ibogaine research timeline

Context before conclusions.

Quiet Harbor 52 assembles plain-language materials for Texans, veterans, families, researchers, policymakers, and clinicians who want to follow an evolving pathway without confusing public interest or trial planning with routine care.

Use the Texas ibogaine research overview to orient around the subject first, then use the services below to compare milestones, terms, and open questions. For the purpose and standards behind this work, see how Quiet Harbor 52 approaches its material.

What we organize

Information built for a moving timeline.

Each offering is informational: it is designed to make research and policy developments more legible, not to assess an individual situation or recommend a course of treatment.

01 / TIMELINE GUIDES

Program milestone guides

Step-by-step explainers place public funding, study development, federal review, and public announcements in sequence. The focus is what a milestone may signal—and what it does not establish about availability or safety.

02 / COMPARISONS

Research versus access

Comparison notes separate research authorization from routine treatment access, helping readers keep different legal and practical questions apart as Texas discussions develop.

03 / RESEARCH SUMMARIES

Evidence in plain language

Research summaries identify what a study is examining, the limits of an early finding, and the safety context that belongs beside efficacy discussions. The National Institute on Drug Abuse’s ibogaine research overview likewise describes ongoing scientific interest while noting important safety concerns.

04 / TERMS & QUESTIONS

Glossary and decision frames

Short definitions and question sets make technical language more usable for non-specialists. This includes context for why a controlled-substance classification matters: the DEA’s scheduling explanation describes how federal schedules shape regulatory treatment of substances.

Landscape view used with the Texas ibogaine program timeline explanation
A timeline is most useful when each step keeps its regulatory and research context.

A practical reading order

Follow the pathway without skipping the boundaries.

The timeline materials are arranged to clarify the difference between a public proposal, a funded research effort, a trial milestone, and a change in ordinary access. That distinction matters because ibogaine has a complex history and remains a subject of regulation; its broader background is summarized in the Wikipedia entry on ibogaine.

  1. 01Start with the public action or policy discussion.
  2. 02Identify the research question, authorization, and trial stage.
  3. 03Keep safety questions visible alongside potential findings.
  4. 04Separate documented milestones from assumptions about routine treatment.
“Research activity can be meaningful without becoming a promise of access, safety, or outcome.”

Common scope questions

What these materials can—and cannot—do.

The goal is to provide organized context for a complicated topic while keeping medical, legal, and regulatory limits visible.

Do these services provide treatment recommendations?

No. Quiet Harbor 52 is an independent information resource. Its guides provide context on research, policy, terminology, and questions to consider; they are not medical or legal advice.

Does research authorization mean routine treatment access?

No. Research authorization and routine treatment access are different questions. A program timeline can help distinguish trial activity, funding, federal constraints, and public discussion from ordinary clinical availability.

Who are the materials intended for?

The materials are for Texans, veterans, families, researchers, policymakers, and clinicians seeking careful context on ibogaine research developments. The stakeholder guide organizes some of the distinct questions different audiences may carry.

Continue with the record

See the timeline in sequence.

For a milestone-by-milestone view of the Texas pathway, continue to the program timeline and use it alongside the explanatory guides on this site.

Program Timeline